Status: Recruiting
HIV Prevention With PrEP Among People on Opioid Replacement Therapy
The purpose of this study is to assess the feasibility and acceptability of providing oral pre-exposure prophylaxis (PrEP) and opioid agonist therapy (OAT) simultaneously in existing pharmacy-based programs operating in Alberta and Saskatchewan, to collect preference, adherence, and persistence data on oral PrEP, and to assess interest / acceptability of long-lasting injectable options for human immunodeficiency virus (HIV) prevention.
Participants needed: 350
Trial details
Phase: Phase 4Age: 16+Biological sex: AllType: InterventionalSponsor: Cara SpenceUpdated: Oct 7, 2025Locations: 6
Eligibility criteria
HIV negative [+3]
Creatine clearance <30 mL/min or any medical condition or medication known to be... [+2]